Serotherapy of cancer
- PMID: 2658082
Serotherapy of cancer
Similar articles
-
Immunotoxin therapy of malignancy.Important Adv Oncol. 1992:111-35. Important Adv Oncol. 1992. PMID: 1582669 Review. No abstract available.
-
Monoclonal antibodies in cancer treatment.Lancet. 1986 Mar 15;1(8481):603-5. doi: 10.1016/s0140-6736(86)92821-7. Lancet. 1986. PMID: 2869313 No abstract available.
-
Monoclonal antibodies in the treatment of cancer.Crit Rev Oncol Hematol. 1984;1(4):357-85. doi: 10.1016/s1040-8428(84)80008-6. Crit Rev Oncol Hematol. 1984. PMID: 6397268 Review.
-
[Immunotoxin therapy of neoplasms].Nihon Rinsho. 1983;41(4):825-9. Nihon Rinsho. 1983. PMID: 6350651 Review. Japanese. No abstract available.
-
[Immunotoxins (author's transl)].Nouv Presse Med. 1982 Apr 10;11(17):1321-4. Nouv Presse Med. 1982. PMID: 7079145 French.
Cited by
-
The production of a bispecific anti-CEA, anti-hapten (4-amino-phthalate) hybrid-hybridoma.J Natl Med Assoc. 1991 Oct;83(10):901-4. J Natl Med Assoc. 1991. PMID: 1800765 Free PMC article.
-
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.Br J Cancer. 1996 Dec;74(11):1749-56. doi: 10.1038/bjc.1996.625. Br J Cancer. 1996. PMID: 8956788 Free PMC article.
-
Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.Cancer Immunol Immunother. 1991;33(6):367-74. doi: 10.1007/BF01741596. Cancer Immunol Immunother. 1991. PMID: 1878890 Free PMC article.
-
Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody.Cancer Immunol Immunother. 1991;32(6):364-72. doi: 10.1007/BF01741331. Cancer Immunol Immunother. 1991. PMID: 1706642 Free PMC article. Clinical Trial.
-
Targeting of superantigens.Cell Biophys. 1993 Jan-Jun;22(1-3):147-64. doi: 10.1007/BF03033872. Cell Biophys. 1993. PMID: 7889537 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources